We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · August 27, 2021

Outcomes of Upfront Auto-HSCT in Older Patients With Multiple Myeloma



Additional Info

Outcomes of Upfront Autologous Hematopoietic Cell Transplantation in Patients With Multiple Myeloma Who Are 75 Years Old or Older
Cancer 2021 Aug 10;[EPub Ahead of Print], PN Munshi, DH Vesole, A St Martin, O Davila, S Kumar, M Qazilbash, N Shah, PN Hari, A D'Souza

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading